Edesa Biotech Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

16.89M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	-	-	-
Sep 30, 2023	-	-	-
Sep 30, 2022	-	-	-
Sep 30, 2021	-	-	-
Sep 30, 2020	328.80K	-82.07K	-19.97%
Sep 30, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
UnitedHealth Group	422.82B
Johnson & Johnson	90.63B
Merck & Co.	63.62B
AbbVie	58.33B
AstraZeneca	56.50B
Novartis AG	55.19B
Eli Lilly and Company	53.26B
Novo Nordisk	49.11B

Revenue Rankings

EDSA News

16 days ago - Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results - GlobeNewsWire
3 months ago - Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results - GlobeNewsWire
4 months ago - Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference - GlobeNewsWire
5 months ago - Edesa Biotech Announces Chief Financial Officer Transition - GlobeNewsWire
6 months ago - Edesa Biotech Reports Fiscal 1st Quarter 2025 Results - GlobeNewsWire
6 months ago - Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
9 months ago - Edesa Biotech Reports Fiscal Year 2024 Results - GlobeNewsWire
10 months ago - Edesa Biotech's Founder Makes Strategic Investment in the Company - GlobeNewsWire

More News